Category Archives: Market Access

Payers, Policy & Pricing: A Head Start on Market Access for Canadian Healthcare Entrepreneurs

Posted on by
Reply

Debbie Milliken presents at JLABS @ Toronto on June 15th with other market access experts.

“Introduction to Market Access” workshop for Canadian healthcare startups.

Topics include:

  • Background on each stage of market access:
    – HTA
    – Pricing
    – Working with Payers to Secure Drug Coverage (Public & Private)
  • A deeper dive into Public & Private Payers
  • How startups should approach & prepare for market access
Share

Debbie Milliken presents on Pan-Canadian Pricing Alliance at CAHR Conference

Posted on by
Reply

The Canadian Association of Healthcare Reimbursement (CAHR) hosts “Biologics – What does the Future Hold?” on June 11, 2014 in Toronto.

Debbie Milliken, Managing Director, MILLREED Enterprises Ltd presents on the Pan-Canadian Pricing Alliance (PCPA) and implications for biologic drugs.

  • Recent changes affecting Biologics – How many Biologics have made it through the process?
  • Special considerations for Biologics?
  • Update on IMB Report

CAHR-Logo380x65a3

Share

pCODR and CPAC Tutorial

Posted on by
Reply

The Pan-Canadian Oncology Drug Review (pCODR) and the Canadian Partnership Against Cancer have developed a useful tutorial addressing questions on how cancer drug funding decisions are made in Canada.

 

 

 

Share